Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma

作者: Edward L. Trimble , Michaele C. Christian

DOI: 10.1016/J.YGYNO.2005.12.006

关键词:

摘要:

参考文章(5)
M. J. Piccart, A. Floquet, G. Scarfone, P. H. B. Willemse, J. Emerich, I. Vergote, L. Giurgea, C. Coens, A. Awada, J. B. Vermorken, Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy. International Journal of Gynecological Cancer. ,vol. 13, pp. 196- 203 ,(2003) , 10.1111/J.1525-1438.2003.13360.X
Joan L. Walker, Deborah K. Armstrong, Helen Q. Huang, Jeffrey Fowler, Kenneth Webster, Robert A. Burger, Daniel Clarke-Pearson, Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study Gynecologic Oncology. ,vol. 100, pp. 27- 32 ,(2006) , 10.1016/J.YGYNO.2005.11.013
Robert E. Bristow, Rafael S. Tomacruz, Deborah K. Armstrong, Edward L. Trimble, F. J. Montz, Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis Journal of Clinical Oncology. ,vol. 20, pp. 1248- 1259 ,(2002) , 10.1200/JCO.2002.20.5.1248
David S Alberts, PY Liu, Edward V Hannigan, Robert O'Toole, Stephen D Williams, James A Young, Ernest W Franklin, Daniel L Clarke-Pearson, Vinay K Malviya, Brent DuBeshter, Mark D Adelson, William J Hoskins, None, Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer The New England Journal of Medicine. ,vol. 335, pp. 1950- 1955 ,(1996) , 10.1056/NEJM199612263352603